WASHINGTON: Pfizer and BioNTech said Tuesday they began submitting a formal request to US health regulators for emergency use of their Covid vaccine for children aged over six months and under five years. If the Food and Drug Administration (FDA) authorizes the two-shot regimen, it will become the first Covid vaccine available to this age group in the United States.
In a tweet soon after the announcement, the FDA said it will hold a meeting on February 15 to consider the request.
Pfizer seeks US approval of Covid vaccine for children under 5
Echoes of the Heart
Kazakh President satisfied with results of talks with Putin
Kazakh President Kassym-Jomart Tokayev signified satisfaction following the lengthy face-to-face talks with President of Russia Vladimir Putin in Sochi, the Facebook account of the President’s press secretary Ruslan Zheldibay reads. During the talks the parties debated a wide range of issues concerning trade and economic, investment, humanitarian cooperation, cooperation of the two nations in the […]Read More »